SK bioscience wins patent case against Moderna in South Korea
US court clears way for Sun Pharma to launch autoimmune disorder drug
Celltrion targets $3.46 bn in sales this year on biosimilars
Celltrion launches autoimmune disease treatment in US
S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar
Celltrion's autoimmune disease treatment gets approval in Europe
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment
